This article is more than 5 years old. Information may no longer be current.
Top news in dry eye
Click Here to Manage Email Alerts
July is Dry Eye Awareness Month, when physicians and agencies aim to increase awareness of the condition, which affects millions of Americans.
In recent years, dry eye disease has increasingly become a priority as studies have been conducted and pharmaceuticals developed to combat its effects.
Here are five important recent advancements in dry eye disease care from Healio.com.
1. Lifitegrast improved dry eye signs, symptoms in five trials
Adults with dry eye disease were assigned to lifitegrast or placebo in five randomized, double-masked, placebo-controlled trials, which found the drug to improve dry eye symptoms. Read more here.
2. Meibomian glands reduced after 3 minutes of intranasal tear neurostimulation
Research presented at the Association for Research in Vision and Ophthalmology annual meeting showed intranasal tear neurostimulation may have a significant effect on meibomian gland morphology. Read more here.
Watch Cynthia Matossian, MD, discuss how the TrueTear neurostimulator from Allergan can be used to treat dry eye here.
3. Stronger association between dry eye, allergy may exist
Survey results have shown migraine headaches and sinus issues as being new risk factors in dry eye. Read more here.
4. Pediatric dry eye disease: The next generation dry eye patient is already here
Darrell E. White, MD, discusses how smartphone use can play a role in dry eye disease, even in children. Read more here.
5. VIDEO: Consider dry eye when choosing PRK or LASIK
Jodi Luchs, MD, FACS, discusses how a patient's risk for ectasia and dry eye must be considered when choosing between PRK and LASIK. Watch here.